NSE: DABUR | BSE: 500096

Expensive Performer

Download real time

492.85 -6.90 (-1.38%)

17.7M NSE+BSE Volume

High volume today

NSE 29 Sep, 2025 3:31 PM (IST)

87,416.3

Market Cap

High in industry

0.6

Beta 1Year

Very Low volatility

Dabur India Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for DABUR, BSE:500096 Dabur India Ltd.

Dabur India Ltd.

07 May 2021

492.85

-1.38%

Q4FY21 Result Update - Peaked out performance, cut to Hold

Hold: Dabur India Ltd.

Target

Prabhudas Lilladhar

Tax rate guidance at 21.5%-22% going forward We are decreasing FY22/23 EPS estimates of Dabur India by 8.0%/5.7% on back of 1) higher tax rate guidance of 21.5-22% (18-18.5% earlier) 2) lower than expected growth in Health Supplements and Healthcare and 3) no margin expansion given input cost pressures. Dabur remains cautiously optimistic given that unlike last year, localized lockdowns would not impact discretionary portfolio and sharp pick up in immunity boosting products demand from 2 nd half of April. We believe that the company will be able to...

Number of FII/FPI investors decreased from 764 to 755 in Jun 2025 qtr

Dabur India Ltd.

02 Feb 2021

492.85

-1.38%

Result Update:Dabur India

Buy: Dabur India Ltd.

Target

Axis Direct

We have kept our estimates unchanged and except double-digit volume growth and strategic shift in A&P; spends. Retain BUY and TP of Rs. 610 as we value the stock at 49x It's FY23E EPS.

Dabur India Ltd. has an average target of 563.57 from 7 brokers.

Dabur India Ltd.

31 Jan 2021

492.85

-1.38%

Dabur India: Q3FY21 Result Review

Accumulate: Dabur India Ltd.

Target

IDBI Capital

DABUR India (DABUR) 3QFY21 result was better than our estimates. Consolidated revenue grew by double-digit for the second consecutive quarter led by strong FMCG domestic volumes (+18%YoY) and double digit revenue growth in international geographies. DABUR has gained market share in most of the categories. Health supplement continued its growth momentum delivering 35%YoY revenue growth driven by strong double digit volume growth and market share gains in Chyawanprash and Honey. In HPC; revenue from hair oil, shampoo and home care witnessed significant recovery. In food portfolio; new launches are tracking well. We maintain...

Number of FII/FPI investors decreased from 764 to 755 in Jun 2025 qtr

Dabur India Ltd.

31 Jan 2021

492.85

-1.38%

Dabur India

Buy: Dabur India Ltd.

Target

ICICI Securities Limited

The company continued to aggressively launch new products across categories. It introduced Himalayan Forest Honey, Dabur Red Pulling Oil, Herb'l toothpaste variants, Premium hair Oil under Vatika & range of products in OTC & Ethical space. Moreover, within previously launched products healthcare juices, Tulsi drops, Dant Rakshak, Herb'l variants & OTC & Ethicals are getting traction. DIL has been very aggressive in new product launches in the last 10 months, which are now contributing 4-5% of sales. We believe renewed focus on health & immunity boosting products has...

Dabur India Ltd. is trading at high day volume of 17.7M.

Dabur India Ltd.

04 Jan 2021

492.85

-1.38%

Pick of the Week:04 JAN 2021

Buy: Dabur India Ltd.

Axis Direct

Dabur India has built a rich ayurvedic heritage spanning over 136 years and is the 4th largest FMCG company in India and a leader in Ayurveda globally. It has a portfolio of over 250 herbal/ayurvedic products available in over 100 countries with International Revenue contributing 27% of revenues.

Dabur India Ltd. is trading below all available SMAs

Dabur India Ltd.

28 Dec 2020, 12:00AM

492.85

-1.38%

Axis Alpha: Dabur India Ltd (BUY)

Buy: Dabur India Ltd.

Target

Axis Direct

We recommend a BUY on DABUR INDIA with a Target Price of Rs 572, an upside of 10% from CMP of Rs. 520 and Stop Loss Rs. 494.

Dabur India Ltd. has an average target of 563.57 from 7 brokers.

Dabur India Ltd.

14 Dec 2020

492.85

-1.38%

Pick of the Week - Dabur

Buy: Dabur India Ltd.

Target

Edelweiss

Dabur has two divisions in India (Consumer care division and Foods division)

Dabur India Ltd. is trading below all available SMAs

Dabur India Ltd.

09 Nov 2020

492.85

-1.38%

DABUR INDIA LTD

Buy: Dabur India Ltd.

Recommendation Target

Geojit BNP Paribas

Dabur India Ltd (Dabur), a leading Indian FMCG company, is a world leader in Ayurveda with a portfolio of over 250 Herbal/Ayurvedic products. The company operates through Health Supplements, Digestives, Shampoos, Hair...

Dabur India Ltd. is trading at high day volume of 17.7M.

Dabur India Ltd.

07 Nov 2020

492.85

-1.38%

Dabur India

Sell: Dabur India Ltd.

Target

Dolat Capital

We have upward revised our FY21E and FY23E EPS estimates at Rs 9.5 (+13%) and Rs 9.8 (+0.8%) and introduced FY23E EPS estimates at Rs10.8. We value the stock at 48x FY23E EPS to arrive at a TP of Rs 520....

Number of FII/FPI investors decreased from 764 to 755 in Jun 2025 qtr

Dabur India Ltd.

05 Nov 2020

492.85

-1.38%

Dabur India

Accumulate: Dabur India Ltd.

Target

Arihant Capital

Dabur India Limited ( Dabur) earnings surprised the market with double digit volume growth in in Q2FY21 . Dabur's domestic business grew 16.8% YoY, much higher than the anticipated mid-single digit growth. Profit for the quarter grew by 19.9%YoY/+41.6% QoQ to Rs 483 Cr above our estimates of Rs 384 cr on the back of growth in topline, higher other Income and lower finance cost during Q2FY21. Consolidated revenue stood at Rs 2516 cr , above our estimates Rs2,274 cr registering a growth of 13.7%YoY/+27.1%QoQ mainly led by healthy growth in...

Dabur India Ltd. is trading below all available SMAs

Is Dabur India Ltd. worth buying?

671 Votes:

Buy 76.6%

Sell 12.22%

Hold 11.18%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf